QuickView for dermatan sulfate metabolic process (biogroup)

1. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
2. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
4. Subcellular fraction from human cell lines - membrane associated and cytoplasmic RNA
5. L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens

There were no matches for dermatan sulfate metabolic process

1. Collection and Study of Cerebrospinal Fluid in Patients With Hunter Syndrome
2. Biomarker for Hurler Disease (BioHurler)
3. A Study of UX003 Recombinant Human Beta-Glucuronidase (rhGUS) Enzyme Replacement Therapy in Subjects…
4. A Multi-cohort Study of the Tolerance, Safety, and Pharmacokinetics of GNR-055 in Healthy Volunteers
5. A Multi-cohort Study of Safety, Efficacy, PK and PD of GNR-055 in Patients With Mucopolysaccharidosi…